Tags » Pharmaceuticals

New in the library reference collection - British Pharmacopoeia 2015

British Pharmacopoeia, 2015 ed. (2014)

The 2015 edition includes almost 3,500 monographs which are legally enforced by the Human Medicines Regulations 2012.

Now used in over 100 countries, the BP remains an essential reference for all individuals and organisations working within pharmaceutical research and development, manufacture and testing around the globe. 97 more words

ZJournal Articles

OTCs In Action Episode 9: Traditional Medicine minister appointed as MNC manufacturing multiplies

OTCs are in Action in India. Indian prime minister and enthusiastic yoga practitioner, Narendra Modi, has appointed Shripad Yesso Naik to be the first minister of the Yoga & Traditional Medicines division of the Health Ministry. 304 more words


Merck To Manufacture Potential Ebola Vaccine

WHITEHOUSE STATION, N.J. (AP) — Merck & Co., one of the world’s top developers and sellers of vaccines, has entered a partnership with a small drug developer to research and manufacture a potential Ebola vaccine now in initial patient testing. 155 more words


Sports Medicines Market: The U.S. Industry Analysis and Forecast to 2020

Sports medicines refer to a branch of medicines that deal with treatment and prevention of the injuries and disorders that are caused by participation in sports and exercise. 262 more words


VancouverSun: Sechelt, BC aims to scrub pharmaceuticals from its wastewater

Via: VancouverSun, November 13, 2014

The District of Sechelt, B.C. is pursuing a unique pilot project that will use recovered sewage solids to remove traces of pharmaceutical drugs, recreational drugs and hormones from post-treatment wastewater. 872 more words

Case Solution for Syntonix Pharmaceuticals

Complete Case details are given below :

Case Name :      Syntonix Pharmaceuticals

Authors :           Raymond M. Kinnunen, Susan F. Sieloff, Robert Young

Source :             North American Case Research Association (NACRA) 199 more words


Controlling the Costs of Innovation: Let's Refocus and Remember The Patient

In a controversial study released this week, Tufts University’s Center for the Study of Drug Development estimates that the cost to bring a new drug to market exceeds nearly 2.6 billion dollars.   643 more words

Optimizing Patient Care